98%
921
2 minutes
20
Objectives: Health technology assessment bodies are increasingly using cost comparison (cost-minimization) analysis to manage rising demand. Such an approach requires demonstration of clinical similarity. Although head-to-head comparisons from equivalence or noninferiority studies are usually accepted as evidence of similarity, guidance is lacking on when equivalence may be assumed from indirect treatment comparison (ITC), either quantitative or qualitative.
Methods: We reviewed methods articles and previous National Institute for Health and Care Excellence appraisals to assess methods for determining equivalence when no head-to-head trial exists, identify how National Institute for Health and Care Excellence and their committees decide if a cost comparison route is suitable, and explore how best to present evidence of similarity to aid decision making.
Results: We identified 5 methods articles, 41 case studies, and 33 appraisals that used cost comparison based on ITC. All 33 appraisals were recommended, although none applied any of the formal methods identified from the literature. Instead, companies used narrative summaries to assert similarity, often based on a lack of significant differences, leading to committee uncertainty that was typically resolved through clinical expert input. The most promising methods we reviewed were the estimation of noninferiority ITCs in a Bayesian framework followed by a straightforward, probabilistic comparison of the indirectly estimated treatment effect against a prespecified noninferiority margin.
Conclusions: Formal methods to assess equivalence in ITC-based cost comparison are emerging but have not yet been applied in practice. We provide recommendations for how these methods and qualitative methods, such as evaluation of the plausibility of class effects and clinical expert input, could help address uncertainties in assuming equivalence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jval.2025.05.003 | DOI Listing |
BJOG
September 2025
Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Objective: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM).
Design: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial.
Setting: Sweden, with risk-factor based screening for GDM.
Sci Justice
September 2025
Department of Analytical, Environmental and Forensic Sciences, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London SE1 9NH, UK. Electronic address:
Wildlife poaching and the trade of wildlife items is a large area of illegal business that is alleged to be worth hundreds of billions of dollars. However, wildlife forensics remains an understudied field even though the consequences of poaching are catastrophic and can lead to the spread of zoonotic disease and a decrease in biodiversity. Even though fingermark analysis is cost-effective, easy to deploy in the field and has a long history of securing criminal convictions in court, wildlife forensics is mainly limited to DNA-based techniques.
View Article and Find Full Text PDFBMJ Open
September 2025
Genentech, South San Francisco, California, USA.
Objectives: Emicizumab is the first bispecific antibody approved for prophylaxis in people with haemophilia A with or without factor VIII inhibitors. Aggregate distributional cost-effectiveness analysis assesses health equity impacts by evaluating how health effects and costs from funding an intervention are distributed among population subgroups. The objective was to evaluate how funding emicizumab for people with severe haemophilia A (PwSHA) impacts population health and health disparities in the USA.
View Article and Find Full Text PDFJMIR Res Protoc
September 2025
National Institute of Public Health, University of Southern Denmark, Copenhagen K, Denmark.
Background: The high and increasing rate of poor mental health among young people is a matter of global concern. Experiencing poor mental health during this formative stage of life can adversely impact interpersonal relationships, academic and professional performance, and future health and well-being if not addressed early. However, only a few of those in need seek help.
View Article and Find Full Text PDFJ Bras Pneumol
September 2025
. Santa Casa de Misericórdia de Mogi Mirim, Mogi Mirim (SP) Brasil.
Objective: Respiratory syncytial virus (RSV) is a major cause of severe respiratory infections in older adults, particularly those with comorbidities. Despite its clinical impact, RSV remains underdiagnosed and underreported. We sought to assess the burden of RSV in older adults (≥ 60 years of age) in Brazil using national surveillance data for the 2022-2023 period.
View Article and Find Full Text PDF